Clinical Trial Results:
            A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908  700mg BID  plus ritonavir  100mg BID  Versus Lopinavir/ritonavir  400mg/100mg  BID  when Administered in Combination with the Abacavir/Lamivudine  600mg/300mg   Fixed-Dose Combination Tablet QD in Antiretroviral-Nave HIV-1 Infected Adults Over 48 Weeks
    
|     Summary | |
|     EudraCT number | 2004-000060-27 | 
|     Trial protocol | IT | 
|     Global completion date | 
                                    31 Jan 2006
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    08 Jul 2016
                             | 
|     First version publication date | 
                                    08 Jul 2016
                             | 
|     Other versions | |
|     Summary report(s) | 100732-Clinical-Study-Result-Summary | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
